Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study-Reference-Cited by-同舟云学术

Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study

Published:2023-05 Issue:5 Volume:4 Page:e309-e318
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Regev-Yochay Gili,Lustig Yaniv,Joseph Gili,Gilboa Mayan,Barda Noam,Gens Ilana,Indenbaum Victoria,Halpern Osnat,Katz-Likvornik Shiri,Levin Tal,Kanaaneh Yara,Asraf Keren,Amit Sharon,Rubin Carmit,Ziv Arnona,Koren Ravit,Mandelboim Michal,Tokayer Noam H,Meltzer Lilac,Doolman Ram,Mendelson Ella,Alroy-Preis Sharon,Kreiss Yitshak

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference33 articles.

1. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

2. COVID-19 vaccines: current conditions and future prospects;Zieneldien;Biology (Basel),2021

3. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients;Amit;Lancet,2021

4. An mRNA vaccine against SARS-CoV-2—preliminary report;Jackson;N Engl J Med,2020

5. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data;Haas;Lancet,2021

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment;Vaccine;2024-11

2. Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines;Vaccine;2024-09

3. SARS-CoV-2 Omicron XBB.1 variant outbreak in a defined cohort: an epidemiological investigation incorporating longitudinal assessment of humoral response;International Journal of Infectious Diseases;2024-09

4. Follow-Up of SARS-CoV-2 Antibody Levels in Belgian Nursing Home Residents and Staff Two, Four and Six Months after Primary Course BNT162b2 Vaccination;Vaccines;2024-08-22

5. Anti‐Spike IgG antibodies as correlates of protection against SARS‐CoV‐2 infection in the pre‐Omicron and Omicron era;Journal of Medical Virology;2024-08